04/16/2026
Labryte will be at the Executive War College this year.
We work closely with companies developing products for clinical laboratories (assays, platforms, software, and services) and help bridge the gap between product development and real world clinical adoption.
That gap is where most products fail.
Regulatory constraints, validation requirements, workflow friction, and reimbursement challenges are often underestimated until it’s too late.
Our founder, Amanda Natalizio, PhD, will be onsite meeting with organizations that want to pressure test their products against actual lab operations and compliance requirements.
This also marks our transition from Helix Molecular Solutions to Labryte, reflecting a more focused approach to helping companies successfully enter and scale in the clinical lab market.
If you’re attending EWC and want honest feedback on how your product will perform in a clinical setting, connect with us.
